1-3 of 3
Neil Johnson
Close
Sort by
Journal Articles

Identification of a Novel Nucleoside Prodrug with Preferential Activity in Lymphoma and Leukemia Subtypes

Marissa L Calbert, Gurushankar Chandramouly, Tatiana Kent, Clare M Adams, Mrityunjay Tyagi, Yifan Wang, John Krais, Hoora Shaghaghi, Jessica Atkins, Tomasz Skorski, Neil Johnson, Christine M Eischen, Richard Pomerantz
Journal: Blood
Blood (2022) 140 (Supplement 1): 10701.
https://doi.org/10.1182/blood-2022-165514
Published: 2022
Journal Articles

TET2 and DNMT3A Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors

Silvia Maifrede, Bac Viet Le, Margaret Nieborowska-Skorska, Konstantin Golovine, Katherine Sullivan-Reed, Wangisa M.B. Dunuwille, Joseph Nacson, Michael Hulse, Lisa Beatrice Caruso, Zachary Gazze, Zhaorui Lian, Antonella Padella, Kumaraswamy Chitrala, Boris Bartholdy, Ksenia Matlawska-Wasowska, Daniela Di Marcantonio, Giorgia Simonetti, Georg Greiner, Stephen M. Sykes, Peter Valent, MD, Elisabeth M. Paietta, Hugo F Fernandez, Martin S. Tallman, MD, Mark Litzow, MD, Mark D. Minden, Jian Huang, Giovanni Martinelli, MD, George S. Vassiliou, MD PhD FRCPath, MRCP, Italo Tempera, Katarzyna Piwocka, Neil Johnson, Grant Challen, Tomasz Skorski, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4.
https://doi.org/10.1182/blood-2020-137658
Published: 2020
Journal Articles

Inhibition Of LSD1 As a Therapeutic Strategy For The Treatment Of Acute Myeloid Leukemia

Ryan G. Kruger, Ph.D., Helai Mohammad, Ph.D., Kimberly Smitheman, Monica Cusan, Yan Liu, Melissa Pappalardi, Kelly Federowicz, Glenn Van Aller, Jiri Kasparec, Xinrong Tian, Ph.D., Dominic Suarez, Meagan Rouse, Ph.D., Jessica Schneck, Jeffrey Carson, Patrick McDevitt, Thau Ho, Charles McHugh, William Miller, Ph.D., Neil Johnson, Ph.D., Scott A. Armstrong, MD, PhD, Peter Tummino, Ph.D.
Journal: Blood
Blood (2013) 122 (21): 3964.
https://doi.org/10.1182/blood.V122.21.3964.3964
Published: 2013